{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:08Z","timestamp":1786119608435,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1097\/mph.0b013e3181edf543","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T05:06:13Z","timestamp":1291266373000},"page":"e54-e59","source":"Crossref","is-referenced-by-count":5,"title":["The RB (pRb2\/p16) and p53 (p14\/p53\/p21) Tumor-suppressor Pathways in Endemic Burkitt Lymphoma"],"prefix":"10.1097","volume":"33","author":[{"given":"Sam","family":"Kalungi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wabinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Bostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181edf543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:43:20Z","timestamp":1786041800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201103000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181edf543","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}